Therapeutic Asset Ratings
4,913 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Rosuvastatin
Dyslipidemia
Korea University Anam Hospital
P4
A
(81)
Semaglutide
Metabolism and Nutrition Disorder
Nordsjaellands Hospital
P4
A
(81)
Setmelanotide
Bardet Biedl Syndrome (BBS)
Tom Hühne
P4
A
(81)
S-Ketamine
Depressive Disorder, Treatment-Resistant
Janssen Korea, Ltd., Korea
P4
A
(81)
Solu-Cortef
Congenital Adrenal Hyperplasia
University of Texas Southwestern Medical Center
P4
A
(81)
Varenicline Tartrate
Smoking Cessation
University of California, San Diego
P4
A
(81)
Alglucosidase Alfa
Pompe Disease
Erasmus Medical Center
P4
A
(80)
Avalglucosidase Alfa
Pompe Disease
Genzyme, a Sanofi Company
P4
A
(80)
Benmelstobart
Limited Stage Small Cell Lung Cancer
Yayi He
P4
A
(80)
Bxcl501
Agitation,Psychomotor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
P4
A
(80)
Bxcl501
Pain, Chronic
Peking Union Medical College Hospital
P4
A
(80)
Bxcl501
Schizophreniform Disorders
BioXcel Therapeutics Inc
P4
A
(80)
Carboplatin
Large Cell Lung Cancer
National Cancer Institute (NCI)
P4
A
(80)
Ferric Carboxymaltose [Ferinject]
Iron Deficiencies
Fundación para la Investigación del Hospital Clínico de Valencia
P4
A
(80)
FERRIC CATION
Iron Deficiencies
Fundación para la Investigación del Hospital Clínico de Valencia
P4
A
(80)
LEVODOPA
Dyskinesias
Sumitomo Pharma Co., Ltd.
P4
A
(80)
Metformin
Diabetes Mellitus
Erbil Polytechnic University
P4
A
(80)
Metformin
Infertility
Peking University Third Hospital
P4
A
(80)
Metformin
Type 1 Diabetes
Heba M. Ismail
P4
A
(80)
Naproxen
Migraine Disorders
IRCCS San Raffaele Roma
P4
A
(80)
NON-REPLICATING RECOMBINANT SELF-COMPLEMENTARY (SC) ADENO-ASSOCIATED VIRUS SEROTYPE 9 (AAV9) VECTOR CONTAINING THE CDNA OF THE SURVIVAL OF MOTOR NEURON 2 (SMN2) GENE UNDER THE CONTROL OF THE HYBRID CYTOMEGALOVIRUS (CMV) ENHANCER/CHICKEN BETA-ACTIN PROMOTER (CBA)
Spinal Muscular Atrophy
Novartis Pharmaceuticals
P4
A
(80)
Pancrelipase
Exocrine Pancreatic Insufficiency
Anagram Therapeutics, Inc.
P4
A
(80)
Pirfenidone
Idiopathic Pulmonary Fibrosis
Endeavor Biomedicines, Inc.
P4
A
(80)
Rasburicase
Tumor Lysis Syndrome
M.D. Anderson Cancer Center
P4
A
(80)
Risdiplam
Muscular Atrophy, Spinal
Scholar Rock, Inc.
P4
A
(80)
Showing 51 to 75 of 4,913 assets
Previous
Page 3 of 197
Next